Literature DB >> 32396388

β-Hydroxybutyrate is reduced in humans with obesity-related NAFLD and displays a dose-dependent effect on skeletal muscle mitochondrial respiration in vitro.

Jacob T Mey1,2, Melissa L Erickson1,2, Christopher L Axelrod1,2,3, William T King1, Chris A Flask4, Arthur J McCullough5, John P Kirwan1,2.   

Abstract

Nonalcoholic fatty liver disease (NAFLD) is characterized by hepatic fat accumulation and impaired insulin sensitivity. Reduced hepatic ketogenesis may promote these pathologies, but data are inconclusive in humans and the link between NAFLD and reduced insulin sensitivity remains obscure. We investigated individuals with obesity-related NAFLD and hypothesized that β-hydroxybutyrate (βOHB; the predominant ketone species) would be reduced and related to hepatic fat accumulation and insulin sensitivity. Furthermore, we hypothesized that ketones would impact skeletal muscle mitochondrial respiration in vitro. Hepatic fat was assessed by 1H-MRS in 22 participants in a parallel design, case control study [Control: n = 7, age 50 ± 6 yr, body mass index (BMI) 30 ± 1 kg/m2; NAFLD: n = 15, age 57 ± 3 yr, BMI 35 ± 1 kg/m2]. Plasma assessments were conducted in the fasted state. Whole body insulin sensitivity was determined by the gold-standard hyperinsulinemic-euglycemic clamp. The effect of ketone dose (0.5-5.0 mM) on mitochondrial respiration was conducted in human skeletal muscle cell culture. Fasting βOHB, a surrogate measure of hepatic ketogenesis, was reduced in NAFLD (-15.6%, P < 0.01) and correlated negatively with liver fat (r2 = 0.21, P = 0.03) and positively with insulin sensitivity (r2 = 0.30, P = 0.01). Skeletal muscle mitochondrial oxygen consumption increased with low-dose ketones, attributable to increases in basal respiration (135%, P < 0.05) and ATP-linked oxygen consumption (136%, P < 0.05). NAFLD pathophysiology includes impaired hepatic ketogenesis, which is associated with hepatic fat accumulation and impaired insulin sensitivity. This reduced capacity to produce ketones may be a potential link between NAFLD and NAFLD-associated reductions in whole body insulin sensitivity, whereby ketone concentrations impact skeletal muscle mitochondrial respiration.

Entities:  

Keywords:  insulin resistance; ketogenesis; liver; nutrient metabolism

Mesh:

Substances:

Year:  2020        PMID: 32396388      PMCID: PMC7468782          DOI: 10.1152/ajpendo.00058.2020

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  63 in total

1.  Effects of exercise and caloric restriction on insulin resistance and cardiometabolic risk factors in older obese adults--a randomized clinical trial.

Authors:  Hussein N Yassine; Christine M Marchetti; Raj K Krishnan; Thomas R Vrobel; Frank Gonzalez; John P Kirwan
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2009-01-20       Impact factor: 6.053

2.  Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease.

Authors:  Kerry L Donnelly; Coleman I Smith; Sarah J Schwarzenberg; Jose Jessurun; Mark D Boldt; Elizabeth J Parks
Journal:  J Clin Invest       Date:  2005-05       Impact factor: 14.808

3.  Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities.

Authors:  A J Sanyal; C Campbell-Sargent; F Mirshahi; W B Rizzo; M J Contos; R K Sterling; V A Luketic; M L Shiffman; J N Clore
Journal:  Gastroenterology       Date:  2001-04       Impact factor: 22.682

Review 4.  Drug Development for Nonalcoholic Fatty Liver Disease: Landscape and Challenges.

Authors:  Prarthana Thiagarajan; Guruprasad P Aithal
Journal:  J Clin Exp Hepatol       Date:  2019-03-13

5.  Impaired ketogenesis and increased acetyl-CoA oxidation promote hyperglycemia in human fatty liver.

Authors:  Justin A Fletcher; Stanisław Deja; Santhosh Satapati; Xiaorong Fu; Shawn C Burgess; Jeffrey D Browning
Journal:  JCI Insight       Date:  2019-04-23

6.  Whole-body substrate metabolism is associated with disease severity in patients with non-alcoholic fatty liver disease.

Authors:  Ilaria Croci; Nuala M Byrne; Stéphane Choquette; Andrew P Hills; Veronique S Chachay; Andrew D Clouston; Trisha M O'Moore-Sullivan; Graeme A Macdonald; Johannes B Prins; Ingrid J Hickman
Journal:  Gut       Date:  2012-10-17       Impact factor: 23.059

Review 7.  Clinical Presentation and Patient Evaluation in Nonalcoholic Fatty Liver Disease.

Authors:  Vaishali Patel; Arun J Sanyal; Richard Sterling
Journal:  Clin Liver Dis       Date:  2016-02-17       Impact factor: 6.126

Review 8.  Epidemiology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis in the United States and the Rest of the World.

Authors:  Mehmet Sayiner; Aaron Koenig; Linda Henry; Zobair M Younossi
Journal:  Clin Liver Dis       Date:  2015-12-14       Impact factor: 6.126

9.  Failure of hyperketonemia to alter basal and insulin-mediated glucose metabolism in man.

Authors:  P R Bratusch-Marrain; R A DeFronzo
Journal:  Horm Metab Res       Date:  1986-03       Impact factor: 2.936

10.  β-Hydroxybutyrate Elicits Favorable Mitochondrial Changes in Skeletal Muscle.

Authors:  Brian A Parker; Chase M Walton; Sheryl T Carr; Jacob L Andrus; Eric C K Cheung; Michael J Duplisea; Esther K Wilson; Carrie Draney; Daniel R Lathen; Kyle B Kenner; David M Thomson; Jeffery S Tessem; Benjamin T Bikman
Journal:  Int J Mol Sci       Date:  2018-08-01       Impact factor: 5.923

View more
  10 in total

Review 1.  Emerging Role of Hepatic Ketogenesis in Fatty Liver Disease.

Authors:  Raja Gopal Reddy Mooli; Sadeesh K Ramakrishnan
Journal:  Front Physiol       Date:  2022-07-04       Impact factor: 4.755

2.  Biomarkers of Redox Balance Adjusted to Exercise Intensity as a Useful Tool to Identify Patients at Risk of Muscle Disease through Exercise Test.

Authors:  Pierre-Edouard Grillet; Stéphanie Badiou; Karen Lambert; Thibault Sutra; Maëlle Plawecki; Eric Raynaud de Mauverger; Jean-Frédéric Brun; Jacques Mercier; Fares Gouzi; Jean-Paul Cristol
Journal:  Nutrients       Date:  2022-04-29       Impact factor: 6.706

3.  Combined effects of a ketogenic diet and exercise training alter mitochondrial and peroxisomal substrate oxidative capacity in skeletal muscle.

Authors:  Tai-Yu Huang; Melissa A Linden; Scott E Fuller; Felicia R Goldsmith; Jacob Simon; Heidi M Batdorf; Matthew C Scott; Nabil M Essajee; John M Brown; Robert C Noland
Journal:  Am J Physiol Endocrinol Metab       Date:  2021-04-12       Impact factor: 5.900

Review 4.  Diet and exercise in NAFLD/NASH: Beyond the obvious.

Authors:  Georg Semmler; Christian Datz; Thomas Reiberger; Michael Trauner
Journal:  Liver Int       Date:  2021-08-21       Impact factor: 8.754

5.  Ketogenic Diet Suppressed T-Regulatory Cells and Promoted Cardiac Fibrosis via Reducing Mitochondria-Associated Membranes and Inhibiting Mitochondrial Function.

Authors:  Jun Tao; Hao Chen; Ya-Jing Wang; Jun-Xiong Qiu; Qing-Qi Meng; Rong-Jun Zou; Ling Li; Jun-Gang Huang; Zong-Kai Zhao; Yu-Li Huang; Hai-Feng Zhang; Jun-Meng Zheng
Journal:  Oxid Med Cell Longev       Date:  2021-04-19       Impact factor: 6.543

Review 6.  The NLRP3 Inflammasome in Non-Alcoholic Fatty Liver Disease and Steatohepatitis: Therapeutic Targets and Treatment.

Authors:  Lili Yu; Wei Hong; Shen Lu; Yanrong Li; Yaya Guan; Xiaogang Weng; Zhiwei Feng
Journal:  Front Pharmacol       Date:  2022-03-08       Impact factor: 5.810

7.  Hmgcs2-mediated ketogenesis modulates high-fat diet-induced hepatosteatosis.

Authors:  Shaza Asif; Ri Youn Kim; Thet Fatica; Jordan Sim; Xiaoling Zhao; Yena Oh; Alix Denoncourt; Angela C Cheung; Michael Downey; Erin E Mulvihill; Kyoung-Han Kim
Journal:  Mol Metab       Date:  2022-04-12       Impact factor: 8.568

8.  NMR-Based Metabolomics to Decipher the Molecular Mechanisms in the Action of Gut-Modulating Foods.

Authors:  Weiwei He; Hanne Christine Bertram
Journal:  Foods       Date:  2022-09-05

9.  Exogenous Ketosis Impairs 30-min Time-Trial Performance Independent of Bicarbonate Supplementation.

Authors:  Chiel Poffé; Felix Wyns; Monique Ramaekers; Peter Hespel
Journal:  Med Sci Sports Exerc       Date:  2021-05-01       Impact factor: 5.411

10.  Nonalcoholic fatty liver disease, circulating ketone bodies and all-cause mortality in a general population-based cohort.

Authors:  Adrian Post; Erwin Garcia; Eline H van den Berg; Jose L Flores-Guerrero; Eke G Gruppen; Dion Groothof; Berend Daan Westenbrink; Margery A Connelly; Stephan J L Bakker; Robin P F Dullaart
Journal:  Eur J Clin Invest       Date:  2021-06-13       Impact factor: 5.722

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.